Author
Listed:
- Johan Lindqvist
(University of Arizona)
- Weikang Ma
(Department of Biology, Illinois Institute of Technology)
- Frank Li
(University of Arizona)
- Yaeren Hernandez
(University of Arizona)
- Justin Kolb
(University of Arizona)
- Balazs Kiss
(University of Arizona)
- Paola Tonino
(University of Arizona)
- Robbert Pijl
(University of Arizona)
- Esmat Karimi
(University of Arizona)
- Henry Gong
(Department of Biology, Illinois Institute of Technology)
- Josh Strom
(University of Arizona)
- Zaynab Hourani
(University of Arizona)
- John E. Smith
(University of Arizona)
- Coen Ottenheijm
(University of Arizona)
- Thomas Irving
(Department of Biology, Illinois Institute of Technology)
- Henk Granzier
(University of Arizona
University of Arizona)
Abstract
Nebulin is a giant protein that winds around the actin filaments in the skeletal muscle sarcomere. Compound-heterozygous mutations in the nebulin gene (NEB) cause typical nemaline myopathy (NM), a muscle disorder characterized by muscle weakness with limited treatment options. We created a mouse model with a missense mutation p.Ser6366Ile and a deletion of NEB exon 55, the Compound-Het model that resembles typical NM. We show that Compound-Het mice are growth-retarded and have muscle weakness. Muscles have a reduced myofibrillar fractional-area and sarcomeres are disorganized, contain rod bodies, and have longer thin filaments. In contrast to nebulin-based severe NM where haplo-insufficiency is the disease driver, Compound-Het mice express normal amounts of nebulin. X-ray diffraction revealed that the actin filament is twisted with a larger radius, that tropomyosin and troponin behavior is altered, and that the myofilament spacing is increased. The unique disease mechanism of nebulin-based typical NM reveals novel therapeutic targets.
Suggested Citation
Johan Lindqvist & Weikang Ma & Frank Li & Yaeren Hernandez & Justin Kolb & Balazs Kiss & Paola Tonino & Robbert Pijl & Esmat Karimi & Henry Gong & Josh Strom & Zaynab Hourani & John E. Smith & Coen Ot, 2020.
"Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism,"
Nature Communications, Nature, vol. 11(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16526-9
DOI: 10.1038/s41467-020-16526-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16526-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.